Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIDAS: Maraviroc + Darunavir/Ritonavir in Treatment-Naive HIV-1
NCT00993148Phase 2Completed
- Sponsor
- Northwestern University
- Start
- May 2010
- Primary completion
- Apr 2013
- Countries
- 1
01
Overview
A Phase 2 trial of maraviroc in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Northwestern University. Started May 2010; status: completed.
02
Drugs
maraviroc
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00993148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00993148.